drugset / Trial / NCT01421563
Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers
RandomizedCrossoverOpen-label
Summary
The purpose of this study is compare the safety and pharmacokinetic characteristics of DP-R202 (Sarpogrelate HCl 300mg, qd) with those of Anplag (Sarpogrelate HCl 100mg, tid) after oral administration in healthy male volunteers.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sarpogrelate | Small molecule | 100 mg | Oral |
| Subject | Sarpogrelate | Small molecule | 300 mg | Oral |
Indications
No indication recorded.